期刊文献+

老年中晚期宫颈癌患者放化疗期间院内感染危险因素分析 被引量:2

Analysis of the risk factors of nosocomial infection of elderly patients with advanced cervical cancer during radiochemotherapy
暂未订购
导出
摘要 目的分析老年中晚期宫颈癌患者放化疗期间发生院内感染的危险因素。方法回顾性分析2013年1月至2016年1月于本院住院治疗的128例年龄≥60岁且国际妇产科联盟(International Federation of Gynecology and Obstetrics,FIGO)分期≥Ⅲ期的宫颈癌患者的临床资料。将放化疗期间发生院内感染的68例患者纳入观察组,将未发生院内感染的60例患者纳入对照组。分析老年中晚期宫颈癌患者放化疗期间发生院内感染的危险因素。结果观察组中10例患者感染部位多于2个,其中以胃肠道最多,其余依次为呼吸道、生殖道、泌尿道、盆腹腔及皮肤。患有糖尿病和(或)肺部疾病、血清白蛋白水平<35 g/L、白细胞计数<2×10~9/L、T淋巴细胞异常(CD3^+T淋巴细胞<0.5或CD4^+/CD8^+T细胞<1.4)、住院总次数>6次及住院总天数>30天是老年中晚期宫颈癌患者放化疗期间发生院内感染的独立危险因素(P<0.05)。结论临床应对体质较差、伴有糖尿病和肺部疾病等基础疾病的老年患者格外谨慎,采取综合措施提高患者营养状况和抵抗力,减少治疗次数,缩短住院天数,降低院内感染发生率。 Objective To analyze the risk factors of nosocomial infection of elderly patients with advanced cervical cancer during radiochemotherapy.Method Retrospective analyzed the clinical data of 128 cases aged more than 60 years old and the International Federation of Gynecology and Obstetrics (FIGO) stage≥Ⅲ of cervical cancer patients from January 2013 to January 2016 in our hospital. 68 patients with nosocomial infection during radiochemotherapy were included into observation group, and 60 patients without nosocomial infection were included into control group. The clinical information were analyzed to evaluate the risk factors of nosocomial infection in elderly patients with advanced cervical cancer during radiochemotherapy.Result There were 10 cases of patients with more than 2 sites of infection in observation group, the location of infection was most gastrointestinal, the other infection sites were respiratory tract, reproductive tract, urinary tract, pelvic cavity, abdominal cavity and skin. Suffered from diabetes and (or) lung disease, serum albumin level〈35 g/L, white blood cell count〈2×10^9/L, T lymphocyte were abnormal (CD3^+T cells〈0.5 or CD4^+/CD8^+T〈1.4), the total number of hospitalization〉6 times and total hospitalization〉30 days were independent risk factors of nosocomial infection in elderly advanced cervical cancer patients during radiochemtherapy (P〈0.05).Conclusion We should pay much attention to the elderly advanced cervical cancer patients during radiochemotherapy, and apply multiple methods to improve nutritional status and resistant capability, reduce the incidence rate of nosocomial infection.
出处 《中国医学前沿杂志(电子版)》 2017年第7期144-147,共4页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
基金 四川省卫生厅科研课题(30325561465)
关键词 宫颈癌 老年患者 放化疗 院内感染 Cervical cancer Elderly patients Radiochemtherapy Nosocomial infection
  • 相关文献

参考文献9

二级参考文献77

  • 1李贤卓,阳丽华,蒋海波,赵蕾,张应辉.老年住院患者5865例院内感染调查分析[J].中国现代医学杂志,2004,14(22):111-113. 被引量:24
  • 2陈英群,杨郁素,李佶祺.肿瘤医院医疗废物的管理[J].护理研究(下半月),2005,19(5):912-913. 被引量:3
  • 3黄彬,薛福英.64例恶性肿瘤患者住院死亡病例医院感染情况分析[J].实用肿瘤学杂志,1996,10(3):46-47. 被引量:10
  • 4Dimopoulos JC, Lang S, Kirisits C, et al. Dose Volume his- togram parameters and local tumor control in magnetic reso- nance Image-Guided cervical cancer brachytherapy[J]. Int J Radiat Oncol Biol Phys, 2009,75 (1) : 56-63.
  • 5Liu ZB, Hou YF, Min-Dong,et al. PA-MSHA inhibits prolif- era-tion and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell lines [J]. J Cell Biochem,2009,J08[J]..195-206.
  • 6Liu ZB, Hou YF, Zhu J, et al. Inhibition of EGFR pathway signal-ing and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-de- pendent manne[J]. Oneogene, 2010,29(20) : 2996-3009.
  • 7Hou J, Liu Y, Liu Y,et al. The MSHA strain of Pseudo- monas aeru? ginosa activated TLR pathway and enhanced HIV-1 DNA vaccineimmunoreactivity[J]. PLoS One, 2012,7 (10) :e47724.
  • 8Brencic A, McFarland KA, McManus HR,et al. The GacS/ GacA signal transduction system of Pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs [J]. Molecular microbiology, 2009,73 (3) : 434-445.
  • 9Reen FJ, Mooij MJ, Holcombe LJ, et al. The Pseudomonas quinol0ne signal (PQS), and its precursor HHQ, modulate interspecies and interkingdom behaviour [J]. FEMS microbi- ology ecology, 2011,77 (2) : 413-428.
  • 10Bang YJ,Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oe- sophageal junction cancer (TOGA): a phase 3, open-label, randomised controlled trial [J]. The Lancet, 2010, 376 (9742) : 687-697.

共引文献124

同被引文献23

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部